Designer Labeling: Drug Safety Reform Proposals Include New Powers for FDA

The time has come when the pharmaceutical industry will have to answer for Vioxx. Congress will address drug safety in 2007. That means FDA could get new authority over the heart and soul of any new drug-the label.

More from Clinical Trials

More from R&D